When available, the Online Course format is included with the hard copy, eBook, or audio book formats!
Start Date: September 14, 2016
Expiration Date: September 13, 2019
Hypertension (HTN) is a common disease that affects millions of Americans without any warning. It is defined as a persistent elevated blood pressure and is a significant risk factor for cardiovascular disease, thus early detection is imperative. Increasing screening and diagnosis of HTN, and improving control of BP with appropriate treatment are important preventative measures to reduce CV morbidity and mortality. Therefore, a systematic understanding of the management of HTN is essential for pharmacists working in direct patient care to help further improve HTN control.
The purpose of this course is to increase the knowledge of pharmacists on the diagnosis, counseling, and management of HTN. Management of treatment-resistant HTN is beyond the scope of this course. After completion of this course, pharmacists will be able to select and implement appropriate first-line and add-on treatment for the management of HTN based on current evidence-based practice guidelines. They will be able to identify appropriate therapeutic goals based on stages of HTN and comorbidities. Additionally, they will be able to provide effective education and counseling on medication management and lifestyle modifications. As a result, these clinicians will be able to incorporate evidence-based strategies, tools, and patient resources into the workflow to enhance quality of care.
Universal Activity Number (UAN) - 0607-0000-16-014-H01-P
Type of Activity - Knowledge
Topic Designator - 01 – Disease State Management/Drug Therapy
- Define hypertension (HTN), the diagnostic criteria of HTN, and the overall purpose of treating HTN.
- Compare and contrast the differences between essential HTN and secondary causes of HTN.
- Describe the pathophysiology of HTN and the regulation of blood pressure (BP).
- Identify the cardiovascular (CV) complications that are associated with HTN and related target-organ damage.
- Interpret the key differences among various clinical treatment HTN guidelines.
- Recognize appropriate ambulatory and home BP monitoring and measurement.
- Describe important elements of patient counseling regarding HTN, lifestyle modification, and drug therapy.
- List clinical considerations of antihypertensive agents.
- Outline evidenced-based pharmacotherapy options used to treat patients with HTN with or without compelling indications, and describe supporting evidence for these recommendations.
- Choose appropriate drug therapy and monitoring plans for patients with HTN.
Thom Kim Nguyen, PharmD, BCPS, CTTS, is a clinical assistant professor of pharmacy practice at the Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey in Piscataway, New Jersey. Dr. Nguyen received her doctor of pharmacy (PharmD) degree from the Ernest Mario School of Pharmacy. She completed 2 years of postgraduate residency training in pharmacy practice and in pharmacotherapy with a focus on ambulatory care. She also obtained board certification in pharmacotherapy in 2013 and tobacco treatment and medication therapy management in 2014.
Her area of practice is in ambulatory care services at Hunterdon Medical Center in Flemington, New Jersey. Dr. Nguyen’s responsibilities include outpatient care at several family medicine practices and at a cardiopulmonary rehabilitation center. With board-approved collaborative practice agreements, Dr. Nguyen is able to deliver and provide services such as anticoagulation management, smoking cessation, and hypertension management to patients and the healthcare team autonomously.
Dr. Nguyen is a member of several national and state pharmacy organizations, including the American Society of Health-System Pharmacists (ASHP), the American College of Clinical Pharmacy (ACCP), and the New Jersey Society of Health-System Pharmacists (NJSHP).
- Contact hours will be awarded for up to one (1) year from date of purchase or through the expiration date indicated above, whichever date comes first.
- You must score 75% or higher on the final exam and complete the course evaluation to pass this course and have your record transmitted to your NABP e-Profile account.
- Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools’ policy not to accept commercial support.
- All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.